Immune privilege of the CNS is not the consequence of limited antigen sampling.
about
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the BrainImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesStructural and functional features of central nervous system lymphatic vessels.Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effectsMultiple Sclerosis and T Lymphocytes: An Entangled StoryLymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?Multifaceted interactions between adaptive immunity and the central nervous system.How Do Meningeal Lymphatic Vessels Drain the CNS?Revisiting the Mechanisms of CNS Immune Privilege.The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis.Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury.A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathwayCCR7 deficient inflammatory Dendritic Cells are retained in the Central Nervous SystemMMP-9 in translation: from molecule to brain physiology, pathology, and therapy.Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.Organ-specific protection mediated by cooperation between vascular and epithelial barriers.Contraction of T cell richness in lung cancer brain metastases.Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.
P2860
Q26778543-B37E3F65-8D57-44E9-AE38-BCC512363EE5Q26798402-0E256516-4256-458E-94C4-7116B48E7E36Q27316769-E9DB5518-8036-4463-B278-9926AACFDEF4Q27928013-4BABB28A-81E9-4B62-9E99-0A358EECF006Q28086853-B84797E0-6141-491D-AFE8-800E7FA30EDEQ30275974-8F2A68C9-59F8-4020-954C-FBE54561EF82Q30276094-4A51BEED-381A-4E0F-9CC7-5FCCA5DA480AQ30276270-6AF04FE9-459A-4B23-ABF4-E5ECCA08733BQ30278584-A89961E4-FC19-482D-A6FA-8F947D206D4CQ36146033-110C62F4-CA4F-4A1F-B386-E9A121AF2D6CQ36905550-CF24AD15-4347-48DB-8996-F305B9562242Q37189154-E183FE5F-77E5-4AAF-9109-EEE026C941CDQ37652166-17D0454D-DD32-4F43-B8D7-2365A36868A5Q38622769-87C7FA9F-0532-489C-AE9C-B97CB2DF83F8Q38634466-9822FD05-D137-45FF-AC05-739A612F5920Q46312498-36A40021-2DE2-47EF-9E2E-398789030EF6Q47825143-966DBCF5-7D58-4535-8094-CA48DFB44D42Q55257766-D472B3BE-E6A8-4B81-B5CE-77E4B57EDCBA
P2860
Immune privilege of the CNS is not the consequence of limited antigen sampling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@en
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@nl
type
label
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@en
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@nl
prefLabel
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@en
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@nl
P2093
P2860
P356
P1433
P1476
Immune privilege of the CNS is not the consequence of limited antigen sampling.
@en
P2093
Adam Sandor
Changying Ling
Jeffrey S Harding
Jozsef Karman
Kelsey Christensen
Matyas Sandor
Melissa G Harris
Mengxue Zhang
Paul Hulseberg
Zsuzsanna Fabry
P2860
P2888
P356
10.1038/SREP04422
P407
P577
2014-03-21T00:00:00Z
P5875
P6179
1000842177